Try a new search

Format these results:

Searched for:

in-biosketch:true

person:safarb01

Total Results:

104


A comparative analysis of staple height used for robotic right colectomy

Hinduja, Pranav; Alam, Iram S; Gulmez, Mehmet; Bornstein, Yadin; Delau, Olivia; Atallah, Chady; Safar, Bashar; Grieco, Michael J
The use of a closed staple height of less than 3.5 mm in right colon resections remains poorly defined, with limited comparative data against the traditionally used 3.5 mm staplers. To compare rates of anastomotic bleeding and other complications between two staple heights (2.5 mm, white cartridge versus 3.5 mm, blue cartridge) used for intracorporeal isoperistaltic ileocolic anastomosis in robotic right hemicolectomies. This is a retrospective study. The investigation is based on data from a tertiary care center. All patients who underwent a robotic right hemicolectomy or robotic extended right hemicolectomy with an intracorporeal isoperistaltic ileocolic anastomosis for dysplasia or cancer from August 2018 to February 2024. The primary outcome was the anastomotic bleeding rate. A total of 120 patients were included of which 64 patients (53.3%) were female. Group 1 comprised of 52 patients (43.3%) in whom white cartridges were used for ileocolic anastomosis, and group 2 had 68 patients (56.6%) for whom a blue cartridge was used either for the resection of the colon, creation of the anastomosis, or both. A total of 14 patients (11.6%) had anastomotic bleeding. This was managed conservatively with hemodynamic monitoring and blood transfusions in 13 patients (93%), and one patient required a lower endoscopy. The incidence of anastomotic bleeding was almost twice as high in group 2 at 14.7% compared to only 7.6% in group 1 (p = 0.23). No anastomotic leaks were observed in this study. The retrospective nature of the study and inclusion of a single specialized center. The use of staplers with reduced staple height while performing robotic right colon resections may reduce the incidence of bleeding complications without an increase in rates of other complications. Further investigation with large-scale and randomized patient populations is warranted to validate these findings.
PMID: 40569493
ISSN: 1863-2491
CID: 5874792

Impact of Neoadjuvant Chemotherapy on Perioperative Morbidity in Combined Resection of Rectal Cancer and Liver Metastases

Done, Joy Z; Papanikolaou, Angelos; Stem, Miloslawa; Radomski, Shannon N; Chen, Sophia Y; Maturi, Jay R; Atallah, Chady; Safar, Bashar
BACKGROUND AND OBJECTIVES/OBJECTIVE:Little is known about the relationship between neoadjuvant chemotherapy (NAC) and perioperative morbidity for patients undergoing combined resection of rectal cancer and sLM. The purpose of this study is to determine the impact of NAC on 30-day morbidity for patients who undergo combined resection of primary rectal cancer and sLM. MATERIALS AND METHODS/METHODS:A retrospective cohort study of patients undergoing combined resection of primary rectal cancer and sLM between 2016 and 2020 at participating NSQIP hospitals. Multivariate logistic regression models were used to assess the relationship between NAC and 30-day morbidity rates. RESULTS:Among 878 patients who underwent combined resection of primary rectal cancer and sLM, 672 (76.54%) received NAC. There were no significant differences in the rates of 30-day overall morbidity between patients who received NAC and those who did not (37.65% vs. 37.68%, p = 0.95). On adjusted analysis, there was no association between receipt of NAC and rates of overall morbidity (adjusted OR = 1.10, 95% CI 0.78-1.56, p = 0.95). CONCLUSIONS:The receipt of NAC does not appear to be associated with increased perioperative morbidity in patients undergoing combined resection of primary rectal cancer and sLM.
PMID: 39803863
ISSN: 1096-9098
CID: 5776312

Robotic sigmoid colectomy and bladder repair for recurrent diverticulitis and colovesical fistula-A Video Vignette [Letter]

Fong, Chloe; Aydinli, H Hande; Atallah, Chady; Safar, Bashar A
PMID: 39429039
ISSN: 1463-1318
CID: 5739472

Robotic removal of a presacral cyst [Letter]

Esen, Eren; Gulmez, Mehmet; Wong, Daniel J; Safar, Bashar; Atallah, Chady
PMID: 38659096
ISSN: 1463-1318
CID: 5702152

Prevalence of cannabis use disorder and perioperative outcomes in adult colectomy patients: A propensity score-matched analysis

Lo, Brian D; Chen, Sophia Y; Stem, Miloslawa; Papanikolaou, Angelos; Gabre-Kidan, Alodia; Safar, Bashar; Efron, Jonathan E; Atallah, Chady
BACKGROUND:The decriminalization of cannabis across the United States has led to an increased number of patients reporting cannabis use prior to surgery. However, it is unknown whether preoperative cannabis use disorder (CUD) increases the risk of postoperative complications among adult colectomy patients. METHODS:Adult patients undergoing an elective colectomy were retrospectively analyzed from the National Inpatient Sample database (2004-2018). To control for potential confounders, patients with CUD, defined using ICD-9/10 codes, were propensity score matched to patients without CUD in a 1:1 ratio. The association between preoperative CUD and composite morbidity, the primary outcome of interest, was assessed. Subgroup analyses were performed after stratification by age (≥50 years). RESULTS:Among 432,018 adult colectomy patients, 816 (0.19%) reported preoperative CUD. The prevalence of CUD increased nearly three-fold during the study period from 0.8/1000 patients in 2004 to 2.0/1000 patients in 2018 (P-trend<0.001). After propensity score matching, patients with CUD exhibited similar rates of composite morbidity (140 of 816; 17.2%) as those without CUD (151 of 816; 18.5%) (p = 0.477). Patients with CUD also had similar anastomotic leak rates (CUD: 5.64% vs. No CUD: 6.25%; p = 0.601), hospital lengths of stay (CUD: 5 days, IQR 4-7 vs. No CUD: 5 days, IQR 4-7) (p = 0.415), and hospital charges as those without CUD. Similar findings were seen among patients aged ≥50 years in the subgroup analysis. CONCLUSIONS:Though the prevalence of CUD has increased drastically over the past 15 years, preoperative CUD was not associated with an increased risk of composite morbidity among adult patients undergoing an elective colectomy.
PMID: 38342773
ISSN: 1432-2323
CID: 5635562

National trends and outcomes of total proctocolectomy and completion proctectomy ileal pouch-anal anastomosis procedures for ulcerative colitis

Chen, Sophia Y; Radomski, Shannon N; Stem, Miloslawa; Done, Joy Z; Caturegli, Giorgio; Atallah, Chady; Efron, Jonathan E; Safar, Bashar
AIM/OBJECTIVE:The purpose of this study is to assess US operative trends and outcomes of ulcerative colitis (UC) patients undergoing total proctocolectomy with ileal pouch-anal anastomosis (TPC-IPAA) or completion proctectomy with IPAA (CP-IPAA). METHODS:Adult UC patients who underwent TPC-IPAA or CP-IPAA were analysed retrospectively using the 2016-2020 American College of Surgeons National Surgical Quality Improvement Program database. Factors associated with 30-day overall and serious morbidity were identified using multivariable logistic regression. RESULTS:A total of 1696 patients were identified, with 958 patients (56.5%) undergoing TPC-IPAA and 738 (43.5%) undergoing CP-IPAA. A greater proportion of TPC-IPAAs were performed each year (except in 2019) compared to CP-IPAAs over the study period (P trend <0.001). Unadjusted analysis showed comparable rates of overall (20.8% vs. 24.4%, P = 0.076) and serious morbidity (14.3% vs. 12.7%, P = 0.352) between TPC-IPAA and CP-IPAA patients. Robotic TPC-IPAA had no differences in complications compared to laparoscopic and open approaches. Robotic CP-IPAA had higher anastomotic leak rates and longer hospital length of stay compared to laparoscopic and open approaches. Obesity was associated with increased odds of overall and serious morbidity for patients who underwent TPC-IPAA. Steroid/immunosuppressive therapy was associated with increased odds of overall and serious morbidity for patients who underwent CP-IPAA. CONCLUSIONS:Obese patients should be informed of their increased morbidity risk and offered counselling on weight loss prior to surgery when feasible. Patients on steroid/immunosuppressive therapy within 30 days preoperatively should not undergo CP-IPAA or should delay surgery until they can be safely off those medications.
PMID: 38302723
ISSN: 1463-1318
CID: 5626842

Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

Liu, I-Chia; Gearhart, Susan; Ke, Suqi; Hu, Chen; Chung, Haniee; Efron, Jonathan; Gabre-Kidan, Alodia; Najjar, Peter; Atallah, Chady; Safar, Bashar; Christenson, Eric S; Azad, Nilofer S; Lee, Valerie; Zaheer, Atif; Birkness-Gartman, Jacqueline E; Reddy, Abhinav V; Narang, Amol K; Meyer, Jeffrey
BACKGROUND/UNASSIGNED:Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease compared to standard neoadjuvant therapy. However, questions remain regarding surgical outcomes and local control in patients who proceed to surgery, particularly when radiation is given first in the neoadjuvant sequence. We report on our institution's experience with patients who underwent short-course radiation therapy, consolidation chemotherapy, and surgery. METHODS/UNASSIGNED:We retrospectively reviewed surgical specimen outcomes, postoperative complications, and local/pelvic control in a large cohort of patients with LARC who underwent neoadjuvant therapy incorporating upfront short-course radiation therapy followed by consolidation chemotherapy. RESULTS/UNASSIGNED:In our cohort of 83 patients who proceeded to surgery, a complete/near-complete mesorectal specimen was achieved in 90 % of patients. This outcome was not associated with the time interval from completion of radiation to surgery. Postoperative complications were acceptably low. Local control at two years was 93.4 % for all patients- 97.6 % for those with low-risk disease and 90.4 % for high-risk disease. CONCLUSION/UNASSIGNED:Upfront short-course radiation therapy and consolidation chemotherapy is an effective treatment course. Extended interval from completion of short-course radiation therapy did not impact surgical specimen quality.
PMCID:10838936
PMID: 38318322
ISSN: 2589-8450
CID: 5632932

Feasibility of robotic multivisceral resections in colorectal cancer patients: a NSQIP-based study

Radomski, Shannon N; Chen, Sophia Y; Done, Joy Zhou; Stem, Miloslawa; Safar, Bashar; Efron, Jonathan E; Atallah, Chady
Multivisceral robotic surgery may be an alternative to sequential procedures in select patients with colorectal cancer who are diagnosed with synchronous lesions or in those who require additional procedures at the time of resection. The aim of this study was to assess utilization of the robot for multivisceral resections and compare the surgical outcomes of this approach to laparoscopic resections. Adult colorectal surgery patients who underwent a colectomy or proctectomy and a concurrent abdominal surgery procedure in the American College of Surgeons NSQIP database (2016-2021) were included. The primary outcomes were 30-day postoperative overall and serious morbidity. Factors associated with morbidity were assessed using a multivariable logistic regression. Of the 3875 patients who underwent simultaneous multivisceral resections, 397 (10.3%) underwent a robotic approach and 962 (24.8%) a laparoscopic approach. Gynecological procedures (38%) comprised the largest proportion of concurrent procedures followed by hepatic resections (18%). On unadjusted analysis, rates of overall morbidity (25.4% vs. 30.0%) and serious morbidity (12.1% vs 12.0%) did not differ between the robotic and laparoscopic approach groups, respectively. The rate of conversion to open was lower for the robotic compared to laparoscopic approach (9.3% vs. 28.8%, p < 0.001), and length of stay was shorter (4 vs. 5, p < 0.001). On adjusted analysis, there was no significant difference in overall (OR 0.87, 95% CI 0.65-1.16, p = 0.34) or serious morbidity (OR 1.12, 95% CI 0.75-1.65, p = 0.59) between the two approaches even after concurrent procedure risk stratification. Robotic multivisceral resections can be performed with acceptable overall and serious morbidity in select patients with colorectal cancer. Rates of conversion and length of stay may be decreased with a robotic approach, and future research is needed to determine the optimal operative approach in this patient population.
PMID: 37837599
ISSN: 1863-2491
CID: 5604622

Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases

Done, Joy Z; Papanikolaou, Angelos; Stem, Miloslawa; Radomski, Shannon N; Chen, Sophia Y; Atallah, Chady; Efron, Jonathan E; Safar, Bashar
BACKGROUND:Preoperative chemotherapy, or neoadjuvant therapy (NAC) can be used to improve resectability but can also have hepatotoxic effects on the future liver remnant. The purpose of this study was to investigate the impact of NAC on 30-day morbidity among patients undergoing a resection of primary colon cancer and synchronous liver metastases (sLM). METHODS:This was a retrospective study using the National Surgical Quality Improvement Program database (2012-2020). The association between NAC and 30-day overall morbidity, the primary outcome, was assessed. Subgroup analyses for low and high-risk procedures were performed. RESULTS:Among 968 patients who underwent the combined resection, 571 (58.99%) received NAC. There was a lower rate of 30-day overall morbidity among patients who received NAC (34.50% vs. 41.56%, p = 0.026) and no difference in rates of postoperative liver failure, bile leak, need for invasive intervention for hepatic procedure, and anastomotic leak. On adjusted analyses, patients who received NAC had decreased odds of overall morbidity (OR 0.73, 95% CI 0.55-0.97, p = 0.031) compared to patients who did not receive NAC. On subgroup analyses, patients who received NAC prior to a low risk combined resection had lower rates of overall morbidity on both adjusted and unadjusted analyses. Among those undergoing high-risk combined resections, there was no difference in overall morbidity. DISCUSSION AND CONCLUSION/CONCLUSIONS:Patients who are deemed to be candidates for preoperative chemotherapy can proceed with planned neoadjuvant chemotherapy prior to combined resection of primary colon cancer and sLM as preoperative neoadjuvant chemotherapy does not appear to be associated with increased postoperative morbidity.
PMID: 37468732
ISSN: 1873-4626
CID: 5535882

Procedure-specific risks of robotic simultaneous resection of colorectal cancer and synchronous liver metastases

Radomski, Shannon N; Chen, Sophia Y; Stem, Miloslawa; Done, Joy Zhou; Atallah, Chady; Safar, Bashar; Efron, Jonathan E; Gabre-Kidan, Alodia
An estimated 25% of patients with colorectal cancer (CRC) present with distant metastases at the time of diagnosis, the most common site being the liver. Although prior studies have reported that a simultaneous approach to resections in these patients can lead to increased rates of complications, emerging literature shows that minimally invasive surgical (MIS) approaches can mitigate this additional morbidity. This is the first study utilizing a large national database to investigate colorectal and hepatic procedure-specific risks in robotic simultaneous resections for CRC and colorectal liver metastases (CRLM). Utilizing the ACS-NSQIP targeted colectomy, proctectomy, and hepatectomy files, 1,721 patients were identified who underwent simultaneous resections of CRC and CRLM from 2016 to 2021. Of these patients, 345 (20%) underwent resections by an MIS approach, defined as either laparoscopic (n = 266, 78%) or robotic (n = 79, 23%). Patients who underwent robotic resections had lower rates of ileus compared to those who had open surgeries. The robotic group had similar rates of 30-day anastomotic leak, bile leak, hepatic failure, and post-operative invasive hepatic procedures compared to both the open and laparoscopic groups. The rate of conversion to open (8% vs. 22%, p = 0.004) and median LOS (5 vs. 6 days, p = 0.022) was significantly lower for robotic compared to laparoscopic group. This study, which is the largest national cohort of simultaneous CRC and CRLM resections, supports the safety and potential benefits of a robotic approach in these patients.
PMID: 37436675
ISSN: 1863-2491
CID: 5537622